We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Antigen Test Designed for Point-of-Care Detection

By LabMedica International staff writers
Posted on 14 Jun 2012
A novel antigen-detection test shows efficacy in rapidly identifying a variety of respiratory viruses at the point of care in a pediatric setting. More...


The automated, MultiAnalyte system, is capable of detecting from a single nasopharyngeal swab specimen eight respiratory viruses including respiratory syncytial virus (RSV); influenza A and B viruses; adenovirus; parainfluenza type 1, 2, and 3 viruses; and Human metapneumovirus.

Scientists at Turku University Hospital (Finland) evaluated the technology's efficacy in a pediatric emergency setting by testing samples from 158 children who had respiratory symptoms or fever, and whose mean age was 1.8 year. The samples were tested by MariPOC as well as by reverse-transcription polymerase chain reaction (RT-PCR).

Results with the MariPOC (ArcDia; Turku, Finland) test showed sensitivities and specificities for viral detection as follows: for the 36 children with RSV, 83% and 99%; for the 20 with influenza B, 85% and 96%; for the six with influenza A, 50% and 99%; for the 12 with adenovirus, 25% and 97%; and for the eight with Metapneumovirus, 50% and 100%.

Lauri Ivaska, MD, the lead author of the study said, "This test is based on fully automated random access immunoassay and delivers preliminary results in 20 minutes and final results in two hours. Approximately 70% of results are ready in 20 minutes. For these purposes we want to make the diagnosis reliable, easy and fast; however, most point-of-care tests for detection of respiratory viruses have limitations in diagnostic performance and clinical usability." Dr. Ivaska added, "The results indicate that whereas sensitivity for influenza and RSV was moderately good, sensitivity for adenovirus was low." The study was presented on May 10, 2012, at the European Society for Pediatric Infectious Diseases (ESPID) 30th Annual Meeting, held in Thessalonica (Greece).

Related Links:
Turku University Hospital
ArcDia



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.